Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Express Scripts Adds Gilead’s Harvoni To 2017 Formularies

Executive Summary

The pharmacy benefit manager says it has been able to negotiate a discount with Gilead enabling it to give both Harvoni and AbbVie’s Viekira Pak preferred formulary placement. Express Scripts also is expanding its indication-based oncology management initiative.

Advertisement

Related Content

Express Scripts Projects Higher Spending In Inflammation, Diabetes, Cancer
Multi-Indication Pricing: Big Hurdles And Actionable Options
Express Scripts, CVS Formulary Updates: Who's In, Who's Out?
Express Scripts on deal for AbbVie's Viekira: more to come beyond hepatitis C

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC097869

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel